{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-029384","form_type":"8-K","ticker":"CLDI","cik":"0001855485","company_name":"Calidi Biotherapeutics, Inc.","filed_at":"2024-07-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.959534+00:00","generated_at":"2026-05-31T15:47:06.789915+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Calidi Biotherapeutics raises $3M from Dr. Ronald Rigor; launches Nova Cell subsidiary with $2M investment","bullets":["Dr. Ronald Rigor invests $1M in Calidi via 698,812 shares at $1.431 and warrants for 600,000 shares at $1.90.","Dr. Rigor invests $2M in Nova Cell subsidiary for 25% fully-diluted equity; IP assigned to Nova Cell.","Dr. Rigor appointed to Scientific and Medical Advisory Board; receives 5,000 stock options.","Exclusive license for Philippines for AAA stem cells and CLD-201; initial revenue expected 2025.","Nova Cell to focus on regenerative medicine, cosmetics, orthopedics; Calidi retains oncology focus."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-029384","json":"https://secwatch.observer/filing/0001493152-24-029384.json","markdown":"https://secwatch.observer/filing/0001493152-24-029384.md","text":"https://secwatch.observer/filing/0001493152-24-029384.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1855485/000149315224029384/0001493152-24-029384-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1855485/000149315224029384/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T15:47:06.789915+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}